While GPC3 alone has a sensitivity of 55.1% and specificity of 97%, a combination of GPC3 and AFP has a sensitivity of 75.7% and specificity of 83.3% for HCC diagnosis when tumors are less than 3 cm (35). Here, AFP is linked to hepatocellular carcinoma.